Literature DB >> 21643555

EQUINE INFECTIOUS ANEMIA VIRUS INFECTION AND IMMUNITY: LESSONS FOR AIDS VACCINE DEVELOPMENT.

Jodi K Craigo1, Ronald C Montelaro.   

Abstract

Entities:  

Year:  2011        PMID： 21643555      PMCID： PMC3107501          DOI： 10.2217/fvl.10.85

Source DB:  PubMed          Journal:  Future Virol        ISSN： 1746-0794            Impact factor:   1.831


× No keyword cloud information.
  3 in total

Review 1.  EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy.

Authors:  Jodi K Craigo; Ronald C Montelaro
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

2.  Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.

Authors:  Jodi K Craigo; Shannon Barnes; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

Review 3.  Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development.

Authors:  R C Montelaro; K S Cole; S A Hammond
Journal:  AIDS Res Hum Retroviruses       Date:  1998-10       Impact factor: 2.205
  3 in total
  4 in total

1.  Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Authors:  Chong Liu; Sheila J Cook; Jodi K Craigo; Frank R Cook; Charles J Issel; Ronald C Montelaro; David W Horohov
Journal:  Vet Immunol Immunopathol       Date:  2014-08-10       Impact factor: 2.046

2.  Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.

Authors:  Jiansen Du; Xuefeng Wang; Jing Ma; Jianxin Wang; Yuyin Qin; Chunhui Zhu; Fang Liu; Yiming Shao; Jianhua Zhou; Wentao Qiao; Xinqi Liu
Journal:  Retrovirology       Date:  2014-03-21       Impact factor: 4.602

3.  Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Chong Liu; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

4.  Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense.

Authors:  Yan Wang; Guanqin Ma; Xue-Feng Wang; Lei Na; Xing Guo; Jiaqi Zhang; Cong Liu; Cheng Du; Ting Qi; Yuezhi Lin; Xiaojun Wang
Journal:  PLoS Pathog       Date:  2022-02-09       Impact factor: 6.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.